|
|
| Research article summary (published 30 Jul 2009): |
Artificial neural network model for the prediction of obsessive-compulsive disorder treatment response.
Full Abstract
Several patients with obsessive-compulsive disorder (OCD) who are refractory to adequate treatment with first-line treatments are considered treatment-resistant. Further surveys were to be implemented to explore the outcome predictors of the antiobsessional response. Such study was aimed at building a model suitable to predict the final outcome of a mixed OCD pharmacologic and nonpharmacologic treatment approaches. We studied 130 subjects with OCD who underwent pharmacologic (with selective serotonin reuptake inhibitors alone or with selective serotonin reuptake inhibitors and risperidone at low dosage) and/or behavioral therapy (using exposure and response prevention techniques). The following variables were used as predictors: symptoms dimension, as resulting from the Yale-Brown Obsessive-Compulsive Scale items factor analysis; neuropsychologic performances; and epidemiologic variables. The treatment response arising from 3 to 6 months of therapy was used as dependent variable. A conventional logistic regression was used to define a previsional model of treatment response and multilayer perceptrons and to supervise an artificial neural network technique. The 46.9% of the sample resulted to be refractory to treatment. Results obtained with the logistic regression model showed that the only predictors of treatment outcome are hoarding symptoms, repeating rituals, and counting compulsions. Furthermore, using all the variables considered in the models, multilayer perceptrons showed highly better predictive performance as compared with the logistic regression models (93.3% vs 61.5%, respectively, of correct classification of cases). Complex interactions between different clinical and neuropsychologic variables are involved in defining OCD treatment response profile, and nonlinear and interactive modeling strategies, that is, supervised artificial neural networks, seem to be more suitable to investigate this complexity than linear techniques.
Author information
Author/s: Salomoni, Giuliana (G); Grassi, Massimiliano (M); Mosini, Paola (P); Riva, Patrizia (P); Cavedini, Paolo (P); Bellodi, Laura (L);
Affiliation: Department of Clinical Neuroscience, School of Pyschology, San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan, Italy.
Journal and publication information
Publication Type: Journal Article
Journal: Journal of clinical psychopharmacology (J Clin Psychopharmacol), published in United States. (Language: eng)
Reference: 2009-Aug; vol 29 (issue 4) : pp 343-9
Dates: Created 2009/07/13; Completed 2009/09/17;
PMID: 19593173, status: MEDLINE (last retrieval date: 9/17/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases.
30 Oct 1995 - Obsessive-compulsive disorder with non-24-hour sleep-wake syndrome.
30 Aug 2002 - A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.
30 Jul 2000 - Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder.
29 Jun 1996 - Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study.
30 Jan 2002 - Risperidone augmentation in the treatment of severe adolescent OCD in SSRI-refractory cases: a case-series.
29 Sep 2004 - Adding risperidone to selective serotonin reuptake inhibitor improves chronic depression.
30 Jan 1998 - Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders.
27 Feb 1997 - [Combination of risperidone and serotonergic antidepressants in refractory obsessive-compulsive disorder]
30 Oct 1998 - Antiobsessional effect of risperidone add-on treatment in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder may be dose-dependent.
29 Apr 2002
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.